Investment Management Corp of Ontario (IMCO)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Investment Management Corp of Ontario (IMCO)’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,046	Closed	-$419K	–	671
2025 Q4	$419K	Sell	7,046 -9,012	-56%	-$491K	0.01%	634
2025 Q3	$870K	Buy	16,058 +4,312	+37%	+$247K	0.01%	507
2025 Q2	$646K	Sell	11,746 -22,586	-66%	-$1.33M	0.01%	476
2025 Q1	$2.43M	Buy	34,332 +29,032	+548%	+$1.95M	0.05%	265
2024 Q4	$348K	Sell	5,300 -1,000	-16%	-$67K	0.01%	319
2024 Q3	$443K	Buy	6,300 +2,100	+50%	+$176K	0.01%	562
2024 Q2	$346K	Buy	4,200 +1,200	+40%	+$99.9K	0.01%	525
2024 Q1	$262K	Sell	3,000 -1,400	-32%	-$125K	0.01%	537
2023 Q4	$424K	Buy	+4,400	New	+$389K	0.01%	501

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Investment Management Corp of Ontario (IMCO)'s BMRN Position: Q1 2026 in Review

Investment Management Corp of Ontario (IMCO) sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2026, closing a stake of 7,046 shares — an estimated $419K sold.

Investment Management Corp of Ontario (IMCO) first reported a position in BMRN in Q4 2023 and held it in 9 quarters. The position peaked at $2.43M in Q1 2025. 559 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

Investment Management Corp of Ontario (IMCO) reported no remaining BioMarin Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Investment Management Corp of Ontario (IMCO) sold 7,046 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $419K.
Investment Management Corp of Ontario (IMCO) first reported a position in BioMarin Pharmaceuticals in Q4 2023 and held it in 9 quarters.
Investment Management Corp of Ontario (IMCO)'s BioMarin Pharmaceuticals position peaked at $2.43M in Q1 2025.
559 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Investment Management Corp of Ontario (IMCO)'s 13F filing for Q1 2026, filed 15 May 2026.